Back to search results

Graft Versus Host Disease-Reduction Strategies for Donor Blood Stem Cell Transplant Patients With Acute Leukemia or Myelodysplastic Syndrome (MDS)

Abroad (travel likely)RecruitingPHASE2

Conditions

Acute Leukemia · Acute Lymphoblastic Leukemia · Acute Myeloid Leukemia · Myelodysplastic Syndrome · Myeloproliferative Neoplasm

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Moffitt Cancer Center, Tampa, Florida, United States

    Contact: Study coordinator (Taiga Nishihori) · taiga.nishihori@moffitt.org · 813-745-4673
    Contact: Principal Investigator (Taiga Nishihori)

  • University of Pittsburgh Cancer Institute (UPCI), Pittsburgh, Pennsylvania, United States

    Contact: Study coordinator (Alison Sehgal) · sehgalar@upmc.edu · 412-623-2861
    Contact: Principal Investigator (Alison Sehgal)

  • Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington, United States

    Contact: Study coordinator (Marie Bleakley) · mbleakle@fredhutch.org · 206-667-6572
    Contact: Principal Investigator (Marie Bleakley)
Study leads

  • Marie Bleakley

    Principal Investigator

    Fred Hutch/University of Washington Cancer Consortium

View source on ClinicalTrials.gov(opens in a new tab)